Former fda director and boston scientific leaders join keyron ahead of human trials of first device with metabolic surgery-like results without incisions

London & boston--(business wire)--keyron appoints former fda and boston scientific leaders as forepass—a breakthrough device for severe metabolic disease—prepares for clinical trials.

BSX Ratings Summary

BSX Quant Ranking